AH Bio Fund II, L.P.

13D and 13G Filings

13D/G filings: 13D on 1 security
Location: Menlo Park, CA
CIK: 0001725721
Form D filings: 1 filing
All SEC filings: View on sec.gov

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Nautilus Biotechnology, Inc. 13D/A Amendment 4 NAUT · 63909J108	NAUT	63909J108	4.9%	6,263,235	13D/A Amendment 4	9/11/2026 Event 9/9/2026
AH Bio Fund II, L.P.			4.5%	5,782,188
AH Equity Partners Bio II, L.L.C.			4.5%	5,782,188
Andreessen Horowitz LSV Fund II, L.P.			0.4%	481,047
AH Equity Partners LSV II, L.L.C.			0.4%	481,047
Marc L. Andreessen			4.9%	6,263,235
Benjamin A. Horowitz			4.9%	6,263,235
Nautilus Biotechnology, Inc. 13D/A Amendment 3 NAUT · 63909J108	NAUT	63909J108	6.0%	7,684,932	13D/A Amendment 3	8/28/2026 Event 8/26/2026
AH Bio Fund II, L.P.			5.6%	7,094,691
AH Equity Partners Bio II, L.L.C.			5.6%	7,094,691
Andreessen Horowitz LSV Fund II, L.P.			0.5%	590,241
AH Equity Partners LSV II, L.L.C.			0.5%	590,241
Marc L. Andreessen			6.0%	7,684,932
Benjamin A. Horowitz			6.0%	7,684,932
Nautilus Biotechnology, Inc. 13D/A Amendment 2 NAUT · 63909J108	NAUT	63909J108	7.1%	9,063,054	13D/A Amendment 2	6/30/2026 Event 6/26/2026
AH Bio Fund II, L.P.			6.6%	8,366,966
AH Equity Partners Bio II, L.L.C.			6.6%	8,366,966
Andreessen Horowitz LSV Fund II, L.P.			0.5%	696,088
AH Equity Partners LSV II, L.L.C.			0.5%	696,088
Marc L. Andreessen			7.1%	9,063,054
Benjamin A. Horowitz			7.1%	9,063,054
Nautilus Biotechnology, Inc. 13D/A Amendment 1 NAUT · 63909J108	NAUT	63909J108	9.9%	12,653,917	13D/A Amendment 1	6/4/2026 Event 6/2/2026
AH Bio Fund II, L.P.			9.2%	11,682,032
AH Equity Partners Bio II, L.L.C.			9.2%	11,682,032
Andreessen Horowitz LSV Fund II, L.P.			0.8%	971,885
AH Equity Partners LSV II, L.L.C.			0.8%	971,885
Marc L. Andreessen			9.9%	12,653,917
Benjamin A. Horowitz			9.9%	12,653,917

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.